Trial
NCT05029960
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
—
Condition
Brain Tumor
Intervention
Brivaracetam
Why stopped
lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-03